HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Growth characteristics of the RL-67 lung tumor -- a new model for experimental therapy of metastatic processes.

Abstract
Implantation of the RL-67 tumor in to the limb muscle of C57Bl strain mice resulted in the tumor growth at the site of implantation and the metastatic process became manifest predominantly in the lungs of all animals. A direct correlation was established between the primary tumor and its metastases. The number of metastases on the 20th day after the transplantation amounted to about 60. The mean survival time of the tumor-bearing mice was approximately 24 days. Seven different substances were administered intraperitoneally to tumor-bearing animals and their effect on the tumor and its metastases was established. It was found out that heparin and carboxymethyldextran led approximately to a 50% decrease in the number of lung metastases in comparison with the controls. A certain "prophylactic" effect on metastases was achieved with Bleomycin. The data of the biological and histological studies suggested that the RL-67 lung tumor may be used as a suitable model for investigation of the factors influencing the tumor metastases.
AuthorsM Karaivanova, H Getov
JournalNeoplasma (Neoplasma) Vol. 25 Issue 5 Pg. 601-7 ( 1978) ISSN: 0028-2685 [Print] Slovakia
PMID740060 (Publication Type: Journal Article)
Chemical References
  • Antineoplastic Agents
  • Dextrans
  • Heparin
  • carboxymethyl dextran
Topics
  • Animals
  • Antineoplastic Agents (therapeutic use)
  • Dextrans (therapeutic use)
  • Disease Models, Animal
  • Heparin (therapeutic use)
  • Lung Neoplasms (drug therapy, pathology, secondary)
  • Mice
  • Mice, Inbred C57BL
  • Neoplasm Metastasis (pathology)
  • Neoplasms, Experimental (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: